The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / HIV Infection: What Rheumatologists Need to Know

HIV Infection: What Rheumatologists Need to Know

June 15, 2015 • By Leonard H. Calabrese, DO, & Elizabeth Kirchner, MSN, CNP

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Although debate took place regarding the epidemiology and significance of these rheumatic manifestations, they clearly were distinct in many ways: they included an array of conditions, some of which were previously unrecognized, such as painful articular syndrome, HIV arthritis and the diffuse lymphocytosis syndrome (DILS). Other inflammatory diseases were also recognized, some of which, at times, were found to have distinctive features; these included reactive arthritis, psoriatic arthritis, spondyloarthropathy and other myopathic diseases and vasculitis, all of which have been extensively reviewed.9,10,11

You Might Also Like
  • Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges
  • Infection Rates for Patients with SLE on Immunosuppressive Drugs
  • History of Infection Linked to Primary Sjögren’s Syndrome
Explore This Issue
June 2015

With the ushering in of the era of cART and the dramatic shift in the clinical epidemiology of HIV disease, a remarkable deceleration of these inflammatory rheumatic complications occurred.11,12 Today, despite the prolongation of life and an aging HIV-infected population, newly trained rheumatologists see few such cases.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In place of those rheumatic complications previously described in patients with advanced disease, a new array of rheumatic disorders have emerged; in addition, a growing number of aging HIV-infected patients appear to have comorbid de novo rheumatic conditions, covering the gamut of systemic autoimmune and autoinflammatory diseases, posing new clinical challenges. Three disorders deserve special attention at present: avascular necrosis, osteoporosis and immune reconstitution inflammatory syndrome.

Avascular Necrosis
Over the past decade, the incidence of avascular necrosis of bone in the HIV-infected population appears to be rising and may be as high as 0.3–3.4/1,000 person years compared with the general population, in which the incidence is estimated at 0.03–0.04/1,000 person years.13 A small study in asymptomatic HIV-infected men based on screening MRI revealed a prevalence of 4.4% in the HIV-positive men and 0% in corresponding uninfected controls.14

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The etiology of this complication is poorly understood, with conflicting data on a number of disease- and treatment-related variables, including the length of exposure to and class of ART, CD4 nadir, presence of hyperlipidemia and history of glucocorticoid use. Regardless, awareness of this complication is now essential in the context of evaluating bone and joint pain in HIV-infected individuals.

Osteoporosis
A substantial body of data now exists to support that low bone density is more prevalent in HIV-positive individuals compared with HIV-negative controls.13 A number of factors, both traditional and disease related, may contribute to bone loss, including the use of certain ARTs, especially in the first few years of therapy.13,15 A loss of 2–6% of bone mineral density has been observed over the first two years of therapy comparable to losses observed in the first two years of menopause in a typical HIV-negative population.15

Pages: 1 2 3 4 5 6 | Single Page

Filed Under: Conditions, Practice Management Tagged With: AIDS, HIV, Infection, patient care, Rheumatoid arthritis, rheumatologistIssue: June 2015

You Might Also Like:
  • Rheumatologists Treating Patients with HIV Face Treatment, Diagnostic Challenges
  • Infection Rates for Patients with SLE on Immunosuppressive Drugs
  • History of Infection Linked to Primary Sjögren’s Syndrome
  • Rheumatoid Arthritis Patients on Biologics Remain At Risk of Infection

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)